This inventor holds 2 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: The Innovative Contributions of Constantine Kreatsoulas
Introduction
Constantine Kreatsoulas is a notable inventor based in Elkins Park, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly through his work on Oxazole derivatives. With a total of 2 patents, his inventions focus on addressing various medical disorders.
Latest Patents
Kreatsoulas's latest patents include innovative Oxazole derivatives that serve as modulators of Fatty Acid Amide Hydrolase (FAAH). These compounds are not only useful as FAAH imaging agents but also play a crucial role in pharmaceutical formulations. The applications of these compounds extend to the treatment of several disorders, including osteoarthritis, rheumatoid arthritis, diabetic neuropathy, postherpetic neuralgia, skeletomuscular pain, fibromyalgia, acute pain, migraine, sleep disorders, Alzheimer’s Disease, and Parkinson's Disease.
Career Highlights
Currently, Kreatsoulas is associated with Merck Sharp & Dohme Corporation, where he continues to advance his research and development efforts. His work has been instrumental in creating effective treatments that improve the quality of life for patients suffering from chronic pain and neurological disorders.
Collaborations
Throughout his career, Kreatsoulas has collaborated with esteemed colleagues such as Philippe G Nantermet and ZhiQiang Yang. These partnerships have fostered a collaborative environment that enhances innovation and the development of new therapeutic solutions.
Conclusion
Constantine Kreatsoulas exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborative efforts continue to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
